888 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
CELG Celgene Corporation $87.23 $61.35B N/A
Article Searches
Celgene Gave This Tech Back to Editas Medicine, but It Could Prove Valuable https://www.fool.com/investing/2019/12/05/celgene-gave-this-tech-back-to-editas-medicine-but.aspx?source=iedfolrf0000001 Dec 05, 2019 - An amended collaboration agreement limited the types of immune cells that will be pursued by the duo, but that could create more value for Editas Medicine in the long run.
Biotech ETF (BBH) Hits New 52-Week High http://www.zacks.com/stock/news/631055/biotech-etf-bbh-hits-new-52-week-high?cid=CS-ZC-FT-etf_news_and_commentary-631055 Nov 21, 2019 - This biotech ETF hits a new 52-week high. Are more gains in store for this ETF?
Top Ranked Growth Stocks to Buy for November 20th http://www.zacks.com/commentary/629197/top-ranked-growth-stocks-to-buy-for-november-20th?cid=CS-ZC-FT-zacks_#1_rank_additions-629197 Nov 20, 2019 - Top Ranked Growth Stocks to Buy for November 20th
Biotech Stock Roundup: MYOV & KRTX Surge, Pipeline Updates From VRTX, CELG & More http://www.zacks.com/stock/news/629204/biotech-stock-roundup-myov-krtx-surge-pipeline-updates-from-vrtx-celg-more?cid=CS-ZC-FT-analyst_blog|stock_roundup-629204 Nov 20, 2019 - Key highlights of the past week include regulatory and pipeline updates along with collaboration deals.
Bristol-Myers Gets FTC Clearance for Celgene Acquisition http://www.zacks.com/stock/news/625557/bristol-myers-gets-ftc-clearance-for-celgene-acquisition?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-625557 Nov 18, 2019 - Bristol-Myers (BMY) obtains FTC permission for the Celgene acquisition and will divest Otezla to Amgen.
Top Ranked Growth Stocks to Buy for November 18th http://www.zacks.com/commentary/625460/top-ranked-growth-stocks-to-buy-for-november-18th?cid=CS-ZC-FT-zacks_#1_rank_additions-625460 Nov 18, 2019 - Top Ranked Growth Stocks to Buy for November 18th
Top Ranked Growth Stocks to Buy for November 14th http://www.zacks.com/commentary/619764/top-ranked-growth-stocks-to-buy-for-november-14th?cid=CS-ZC-FT-zacks_#1_rank_additions-619764 Nov 14, 2019 - Top Ranked Growth Stocks to Buy for November 14th
Biotech Stock Roundup: SLDB Plunges, CELG Gets FDA Nod for Reblozyl & Other Updates http://www.zacks.com/stock/news/618288/biotech-stock-roundup-sldb-plunges-celg-gets-fda-nod-for-reblozyl-other-updates?cid=CS-ZC-FT-analyst_blog|stock_roundup-618288 Nov 13, 2019 - Key highlights of the past week include regulatory and pipeline updates along with collaboration deals.
Top Ranked Growth Stocks to Buy for November 12th http://www.zacks.com/commentary/615843/top-ranked-growth-stocks-to-buy-for-november-12th?cid=CS-ZC-FT-zacks_#1_rank_additions-615843 Nov 12, 2019 - Top Ranked Growth Stocks to Buy for November 12th
Celgene (CELG) Hits 52-Week High, Can the Run Continue? http://www.zacks.com/stock/news/614198/celgene-celg-hits-52-week-high-can-the-run-continue?cid=CS-ZC-FT-52_week_high-614198 Nov 11, 2019 - Celgene (CELG) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Pages: 123456...89

Page 1>